Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aleksander V. Polyakov"'
Autor:
Anna O Sedova, Maria I Shtaut, Elizaveta E Bragina, Tatyana M Sorokina, Galina V Shmarina, Marina V Andreeva, Lyubov F Kurilo, Stanislav A Krasovskiy, Aleksander V Polyakov, Vyacheslav B Chernykh
Publikováno v:
Asian Journal of Andrology, Vol 25, Iss 5, Pp 591-597 (2023)
We examined a cohort of 93 cystic fibrosis (CF) male patients who were pancreatic-sufficient (PS-CF; n=40) or pancreatic-insufficient (PI-CF; n = 53). Complex semen examination was performed, including standard semen analysis, quantitative karyologic
Externí odkaz:
https://doaj.org/article/ce8be57f3df641f39b1392336f6cd004
Autor:
Polina Gundorova, Irina A Kuznetcova, Galina V Baydakova, Anna A Stepanova, Yulia S Itkis, Victoria S Kakaulina, Irina P Alferova, Lidya V Lyazina, Lilya P Andreeva, Ilya Kanivets, Ekaterina Y Zakharova, Sergey I Kutsev, Aleksander V Polyakov
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249608 (2021)
A timely detection of patients with tetrahydrobiopterin (BH4) -deficient types of hyperphenylalaninemia (HPABH4) is important for assignment of correct therapy, allowing to avoid complications. Often HPABH4 patients receive the same therapy as phenyl
Externí odkaz:
https://doaj.org/article/5dbaf00685114359bc4be7ef84a9e5cb
Autor:
Polina Gundorova, Anna A Stepanova, Irina A Kuznetsova, Sergey I Kutsev, Aleksander V Polyakov
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0211048 (2019)
Phenylalanine hydroxylase (PAH) deficiency is responsible for most cases of phenylketonuria (PKU). Furthermore, numerous studies on BH4-sensitive PAH deficiency have been conducted. To date, BH4, a cofactor of PAH, has not been used to treat PKU in R
Externí odkaz:
https://doaj.org/article/eeb463ec45e64690b4f4972f70970559
Autor:
Polina Gundorova, Rena A Zinchenko, Irina A Kuznetsova, Elena A Bliznetz, Anna A Stepanova, Aleksander V Polyakov
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0201489 (2018)
Phenylketonuria is an inherited disease caused by mutations in the phenylalanine hydroxylase gene PAH. Different PAH pathogenic variants occur in different ethnic groups with various frequencies and the incidence of the disease itself varies from cou
Externí odkaz:
https://doaj.org/article/570b62a7c4f0497da42b047ea3d83800
Autor:
L Selimzianova, Aleksander V. Polyakov, N.B. Kuzmenko, Leyla Namazova-Baranova, N I Ilina, Eliso M. Dzhobava, Elena Vishneva, Tatiana V. Latysheva, Irina A. Manto, A.N. Pampura, Elena A. Latysheva, Anna Shcherbina, E. A. Bliznetz, Natalia M. Nenasheva, E. A. Viktorova
Publikováno v:
Russian Journal of Allergy. 18:77-114
Hereditary angioedema is a rare, potentially life-threatening genetic disease that manifests with skin and mucous/submucosal swelling that occurs under the influence of bradykinin. The clinical guidelines for hereditary angioedema (code for the Inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::898313a0f43f8d92c837318e6ed2f0a8
https://doi.org/10.36691/rja1447
https://doi.org/10.36691/rja1447
Autor:
Daria O. Timoshenko, Aleksander V. Polyakov, Liubov V. Aleshina, Tatiana V. Latysheva, Elvira R. Gilvanova, Galina A. Kameneva, Elena A. Latysheva, Maria A. Platonova, Valentina A. Fedorova, E. A. Bliznetz, Yulia A. Bocherova, Irina A. Manto
Publikováno v:
Russian Journal of Allergy. 18:5-19
BACKGROUND: In 2018, a new form of hereditary angioedema without C1-inhibitor deficiency hereditary angioedema with a mutation in the plasminogen gene was identified. The world scientific literature describes a small number of patients with this form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763c16f20743e07b6e7dff7c1b500c91
https://doi.org/10.36691/rja1446
https://doi.org/10.36691/rja1446
Autor:
Irina P Alferova, Lilya P Andreeva, Aleksander V. Polyakov, Anna A. Stepanova, Victoria S. Kakaulina, Ekaterina Zakharova, Ilya V. Kanivets, Galina Baydakova, Sergey I. Kutsev, Irina A Kuznetcova, Lidya V Lyazina, Polina Gundorova, Yulia S. Itkis
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249608 (2021)
PLoS ONE
PLoS ONE
A timely detection of patients with tetrahydrobiopterin (BH4) -deficient types of hyperphenylalaninemia (HPABH4) is important for assignment of correct therapy, allowing to avoid complications. Often HPABH4 patients receive the same therapy as phenyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a46d8d080f4af0fc8f79e3f12b1dd5
https://doaj.org/article/5dbaf00685114359bc4be7ef84a9e5cb
https://doaj.org/article/5dbaf00685114359bc4be7ef84a9e5cb